Literature DB >> 12955726

CFTR genotypes in patients with normal or borderline sweat chloride levels.

Delphine Feldmann1, Remy Couderc, Marie-Pierre Audrezet, Claude Ferec, Thierry Bienvenu, Marie Desgeorges, Mireille Claustres, Hervé Mittre, Martine Blayau, Dominique Bozon, Marie-Claire Malinge, Nicole Monnier, Jean-Paul Bonnefont, Albert Iron, Eric Bieth, Viviane Dumur, Christine Clavel, Cécile Cazeneuve, Emmanuelle Girodon.   

Abstract

In recent years, some patients bearing "atypical" forms of cystic fibrosis (CF) with normal sweat chloride concentrations have been described. To identify the spectrum of mutant combinations causing such atypical CF, we collected the results of CFTR (ABCC7) mutation analysis from 15 laboratories. Thirty patients with one or more typical symptoms of the disease associated with normal or borderline sweat chloride levels and bearing two CFTR mutations were selected. Phenotypes and genotypes of these 30 patients are described. A total of 18 different CFTR mutations were observed in the 60 chromosomes analysed. F508del was present in 31.6 % of the mutated chromosomes and 3849+10kbC>T in 13.3 %. R117H, D1152H, L206W, 3272-26A>G, S1235R, G149R, R1070W, S945L, and the poly-T tract variation commonly called IVS8-5T were also observed. The relative frequency of CFTR mutations clearly differed from that observed in typical CF patients or in CBAVD patients with the same ethnic origin. A mild genotype with one or two mild or variable mutations was observed in all the patients. These findings improve our understanding of the distribution of CFTR alleles in CF with normal or borderline sweat chloride concentrations and will facilitate the development of more sensitive CFTR mutation screening. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12955726     DOI: 10.1002/humu.9183

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  11 in total

1.  A rare CFTR intronic mutation related to a mild CF disease in a 12-year-old girl.

Authors:  Nadia Nathan; Emmanuelle Girodon; Annick Clement; Harriet Corvol
Journal:  BMJ Case Rep       Date:  2012-11-09

Review 2.  Precision Genomic Medicine in Cystic Fibrosis.

Authors:  Eugene H Chang; Joseph Zabner
Journal:  Clin Transl Sci       Date:  2015-06-15       Impact factor: 4.689

3.  p.Ser1235Arg should no longer be considered as a cystic fibrosis mutation: results from a large collaborative study.

Authors:  Céline René; Damien Paulet; Emmanuelle Girodon; Catherine Costa; Guy Lalau; Julie Leclerc; Faïza Cabet-Bey; Thierry Bienvenu; Martine Blayau; Albert Iron; Hervé Mittre; Delphine Feldmann; Caroline Guittard; Mireille Claustres; Marie des Georges
Journal:  Eur J Hum Genet       Date:  2010-08-18       Impact factor: 4.246

4.  Localization studies of rare missense mutations in cystic fibrosis transmembrane conductance regulator (CFTR) facilitate interpretation of genotype-phenotype relationships.

Authors:  Kristina V Krasnov; Maria Tzetis; Jie Cheng; William B Guggino; Garry R Cutting
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

5.  Classic respiratory disease but atypical diagnostic testing distinguishes adult presentation of cystic fibrosis.

Authors:  Claire L Keating; Xinhua Liu; Emily A Dimango
Journal:  Chest       Date:  2009-12-04       Impact factor: 9.410

6.  Mutations at arginine 352 alter the pore architecture of CFTR.

Authors:  Guiying Cui; Zhi-Ren Zhang; Andrew R W O'Brien; Binlin Song; Nael A McCarty
Journal:  J Membr Biol       Date:  2008-04-18       Impact factor: 1.843

7.  Rescue of CFTR NBD2 mutants N1303K and S1235R is influenced by the functioning of the autophagosome.

Authors:  Qiangni Liu; Inna Sabirzhanova; Murali K Yanda; Emily A S Bergbower; Clément Boinot; William B Guggino; Liudmila Cebotaru
Journal:  J Cyst Fibros       Date:  2018-06-20       Impact factor: 5.482

8.  Rescue of NBD2 mutants N1303K and S1235R of CFTR by small-molecule correctors and transcomplementation.

Authors:  Daniele Rapino; Inna Sabirzhanova; Miquéias Lopes-Pacheco; Rahul Grover; William B Guggino; Liudmila Cebotaru
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

9.  A Case of Cystic Fibrosis With a Rare Mutation (3849 + 10 kbC > T) and Normal Sweat Chloride Levels.

Authors:  Taha Resid Ozdemir; Ali Kanik
Journal:  Iran J Pediatr       Date:  2015-04-18       Impact factor: 0.364

10.  Disease-relevant mutations alter amino acid co-evolution networks in the second nucleotide binding domain of CFTR.

Authors:  Gabrianne Ivey; Robert T Youker
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.